ZNF77 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 58 results for "ZNF77"
i
  1. Transcription profiling of testicular seminoma tumour stages (pT1, pT2, pT3) and 3 normal testes ArrayExpress

    ID: E-GEOD-8607

    Description: rrays in 40 specimens of different tumour stages (pT1, pT2, pT3) and in 3 normal testes. Experiment Overall Design: A total of 40 pure seminoma including 22 samples of tumour stage 1 (pT1), 14 samples of tumour stage 2 (pT2) and 4 of tumour stage 3 (pT3) ...

  2. Gene expression profiling of testicular seminoma BioProject

    ID: PRJNA101777

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: rrays in 40 specimens of different tumour stages (pT1, pT2, pT3) and in 3 normal testes. Keywords: ordered Overall design: A total of 40 pure seminoma including 22 samples of tumour stage 1 (pT1), 14 samples of tumour stage 2 (pT2) and 4 of tumour stage 3...
  3. IGR_BLADDER_GE_STUDY_JA ArrayExpress

    ID: E-MTAB-993

    Description: 2007 to May 2008 (108 bladder tumours (45 pTa, 35 pT1 and 28> pT1)). Microarray analysis was performed with Agilent Technologies Human Whole Genome 4 x 44K oligonucleotide microarrays and used a method of dual color type versus a reference consists of a pool of tumours. From the lists of genes provided by the BrB Class Comparison analyses, we validated the microarray results of 38 selected differentially expressed genes by RT-QPCR in another bladder tumour cohort (n = 95). Results: The cluster “superficial vs invasive stage” properly classified 92.9% of invasive stages and 66.3% of superficial stages. Among...

  4. Gene expression profiling of testicular seminoma GEMMA

    ID: 633

    Keywords: functional genomics

    Description: rrays in 40 specimens of different tumour stages (pT1, pT2, pT3) and in 3 normal testes. Last Updated (by provider): Jul 31 2007 Contributers: Isabella Gashaw Ludger Klein-Hitpass Elke Winterhager...

  5. A Genome-Wide Association Study in Patients Experiencing Breast Events While Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer on NCIC C... BioProject

    ID: PRJNA306194

    Access Type: download

    dataset.description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been estrogen receptor (ER) and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis... (for more see dbGaP study page.)...
  6. PGRN-RIKEN Mayo Breast Cancer BioProject

    ID: PRJNA75545

    Access Type: download

    dataset.description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been ER and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis, prior... (for more see dbGaP study page.)...
  7. A Genome-Wide Association Study in Patients Experiencing Breast Events While Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer on NCIC C... BioProject

    ID: PRJNA306195

    Keywords: Phenotype or Genotype

    Access Type: download

    dataset.description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been estrogen receptor (ER) and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis... (for more see dbGaP study page.)...
  8. TRI77_HUMAN UniProt:Swiss-Prot

    ID: I1YAP6

    Description: Tripartite motif-containing protein 77 B30.2/SPRY RING-type B box-type

  9. PGRN-RIKEN Mayo Breast Cancer BioProject

    ID: PRJNA75547

    Keywords: Phenotype or Genotype

    Access Type: download

    dataset.description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been ER and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis, prior... (for more see dbGaP study page.)...
  10. GWAS of Breast Events with Adjuvant Aromatase Inhibitors dbGaP

    ID: phs001043.v1.p1

    Description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been estrogen receptor (ER) and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis, prior adjuvant chemotherapy, and trastuzumab use and were randomized to 5 years of adjuvant therapy with anastrozole or exemestane. The trial was activated on May 26, 2003, and reached its accrual objectives on July 31, 2008, after the randomization of 6827 North American patients, with the majority (79%) providing DNA and consent for genetic testing. Non-North American patients were also entered by the International Breast Cancer Study Group but they did not contribute DNA. From 2003 to December 2...

    Study Types: Case-Control

  11. MPN TGS2 Follow up PT1 Vori other OmicsDI

    ID: EGAS00001000765

    Date Released:

    Description: cing of 94 known myeloid genes across MPN trials (PT1 and Voriconazole study) as well as remaining MPN samples. New bait design Jan 2014....

  12. Transcription profiling of testicular seminoma tumour stages (pT1, pT2, pT3) and 3 normal testes OmicsDI

    ID: E-GEOD-8607

    Date Released: 03-27-2012

    Description: rrays in 40 specimens of different tumour stages (pT1, pT2, pT3) and in 3 normal testes. Experiment Overall Design: A total of 40 pure seminoma including 22 samples of tumour stage 1 (pT1), 14 samples of tumour stage 2 (pT2) and 4 of tumour stage 3 (pT3) ...

  13. Predictive Gene Signatures as Strong Prognostic Indicators of the Effectiveness of BCG Immunotherapy OmicsDI

    ID: E-GEOD-19423

    Date Released: 05-01-2014

    Description: Calmette–Guérin (BCG) Immunotherapy in Primary pT1 Bladder Cancers Intravesical BCG immunotherapy is effective in prevention of recurrence and progression in many cases of non-muscle invasive bladder cancer, but many patients fail to respond. This study identified predictive gene s...

  14. Solution NMR structure of protein hp1203 from Helicobacter pylori 26695. Northeast Structural Genomics Consortium (NESG) target PT1/Ontari... PDB

    ID: PDB:2K0Z

    Description: Uncharacterized protein hp1203

  15. Predictive Gene Signatures as Strong Prognostic Indicators of the Effectiveness of BCG Immunotherapy ArrayExpress

    ID: E-GEOD-19423

    Description: Calmette–Guérin (BCG) Immunotherapy in Primary pT1 Bladder Cancers Intravesical BCG immunotherapy is effective in prevention of recurrence and progression in many cases of non-muscle invasive bladder cancer, but many patients fail to respond. This study identified predictive gene s...

  16. OCPT1_LEPPU UniProt:Swiss-Prot

    ID: C0HJZ6

    Description: Ocellatin-PT1 Valine amide

  17. Identification and Characterization of MicroRNAs from Phaeodactylum tricornutum by High-throughput Sequencing and Bioinformatics Analysis OmicsDI

    ID: E-GEOD-29321

    Date Released: 08-21-2013

    Description: sRNA) libraries from P. tricornutum under normal (PT1), nitrogen-limited (PT2) and silicon-limited (PT3) conditions. A total of 13 miRNAs were identified. They were probable P. tricornutum-specific novel miRNAs. These miRNAs were differentially expressed in PT1, PT2 and PT3, and their potential targets were involved in various processes. Our results indicated that P. tricornutum contained novel miRNAs that differed from miRNAs of other organisms and that they might play important regulator roles in P. tricornutum metabolism. Constructing and sequencing small RNA (sRNA) libraries from P. tricornutum under normal (PT1), nitrogen-limited (PT2) and silicon-limited (PT3) conditions...

  18. Multilayered control of alternative splicing regulatory networks by transcription factors (SPAR-Seq) BioProject

    ID: PRJNA318263

    Keywords: Other

    Access Type: download

    dataset.description: re transcription factors. Further analyses of the zinc finger protein Zfp871 and BTB/POZ domain transcription factor Nacc1, which regulate neural and stem cell AS programs, respectively, reveal roles in controlling the expression of specific splicing regulators. Surprisingly, these proteins also appear to regulate target AS programs via binding RNA. Our results thus uncover a large ‘missing cache’ of splicing regulators among annotated transcription factors, some of which dually regulate AS through direct and indirect mechanisms. Overall design: Alternative splicing and/or expression of 50 genes was monitored in 1,536 siRNA-mediated knockdowns, including 120 control...
  19. PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study dbGaP

    ID: phs000210.v1.p1

    Description: in the following TMN categories (AJCC Version 6): pT1, pT2, pT3; pNx, pN0, pN1, pN2, pN3 (only when the sole basis is presence of 10 or more involved axillary nodes); MO. The primary tumor must have been ER and/or progesterone receptor positive. Patients were stratified by lymph node status at diagnosis, prior adjuvant chemotherapy, and trastuzumab use and were randomized to 5 years of adjuvant therapy with anastrozole or exemestane. The trial was activated on May 26, 2003, and reached its accrual objectives on July 31, 2008, after the randomization of 6827 North American patients, with the majority (79%) providing DNA and consent for genetic testing. Non-North American patients were also entered by the International Breast Cancer Study Group but they did not contribute DNA. From 2003 to December 21, 2004, patients also ...

    Study Types: Nested Case-Control

  20. Identification and Characterization of MicroRNAs from Phaeodactylum tricornutum by High-throughput Sequencing and Bioinformatics Analysis ArrayExpress

    ID: E-GEOD-29321

    Description: sRNA) libraries from P. tricornutum under normal (PT1), nitrogen-limited (PT2) and silicon-limited (PT3) conditions. A total of 13 miRNAs were identified. They were probable P. tricornutum-specific novel miRNAs. These miRNAs were differentially expressed in PT1, PT2 and PT3, and their potential targets were involved in various processes. Our results indicated that P. tricornutum contained novel miRNAs that differed from miRNAs of other organisms and that they might play important regulator roles in P. tricornutum metabolism. Constructing and sequencing small RNA (sRNA) libraries from P. tricornutum under normal (PT1), nitrogen-limited (PT2) and silicon-limited (PT3) conditions...


Displaying 20 of 58 results for "ZNF77"